|

Degarelix Clinical Trials

9 actively recruiting trials across 9 locations

▼ -1 trial since June 2026

Also known as: ASP 3550, ASP-3550, ASP3550, FE 200486, FE-200486 +5 more

Pipeline

Phase 2: 6Phase 3: 2Phase 4: 1

Top Sponsors

  • University of Colorado, Denver1
  • SWOG Cancer Research Network1
  • Memorial Sloan Kettering Cancer Center1
  • Mayo Clinic1
  • M.D. Anderson Cancer Center1

Indications

  • Cancer8
  • Stage IVB Prostate Cancer AJCC v83
  • Prostate Cancer3
  • Biochemically Recurrent Prostate Carcinoma2
  • Stage IVA Prostate Cancer AJCC v82

Anchorage, Alaska1 trial

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Anchorage Associates in Radiation Medicine

Phase 3

Gilbert, Arizona1 trial

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Banner MD Anderson Cancer Center

Phase 3

Phoenix, Arizona1 trial

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Mayo Clinic in Arizona

Phase 2

Duarte, California1 trial

Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer

City of Hope Medical Center

Phase 2

Aurora, Colorado1 trial

Cardiometabolic Consequences of the Loss of Ovarian Function

University of Colorado Anschutz Medical Campus

Phase 4

Washington D.C., District of Columbia1 trial

ETHAN - ET for Male BC

Georgetown University Medical Center

Phase 2

Miami, Florida1 trial

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Miami Cancer Institute at Baptist Health, Inc.

Phase 2

Basking Ridge, New Jersey1 trial

A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Phase 2

Houston, Texas1 trial

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.